ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

IKNA Ikena Oncology Inc

1.325
0.015 (1.15%)
Última actualización: 08:50:34
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Ikena Oncology Inc IKNA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.015 1.15% 1.325 08:50:34
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.32 1.32 1.33 1.31
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/4/202407:00GLOBEIkena Oncology to Present at the Stifel 2024 Virtual..
12/3/202407:00GLOBEIkena Oncology Reports Fourth Quarter and Full Year 2023..
05/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/2/202407:00GLOBEIkena Oncology to Participate in TD Cowen 44th Annual Health..
21/2/202415:29EDGAR2Form 8-K - Current report
21/2/202415:15GLOBEIkena Oncology Appoints Caroline Germa, M.D. as Chief..
02/2/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:26EDGAR2Form 8-K - Current report
18/1/202415:05GLOBEIkena Oncology Outlines Key Priorities and Provides..
09/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:09EDGAR2Form 8-K - Current report
09/11/202306:00GLOBEIkena Oncology Shares Initial Positive and Differentiated..
07/11/202307:00GLOBEIkena Oncology to Present at Multiple November 2023 Investor..
11/10/202316:10EDGAR2Form 8-K - Current report
25/9/202315:05EDGAR2Form DEF 14A - Other definitive proxy statements
15/9/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
12/9/202315:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/9/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
05/9/202307:00GLOBEIkena Oncology to Participate in September 2023 Investor..
18/8/202315:02EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202307:00GLOBEIkena Oncology Reports Second Quarter 2023 Financial Results..
10/8/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202307:02EDGAR2Form 8-K - Current report
07/8/202306:00GLOBEIkena Oncology Acquires Pionyr Immunotherapeutics in..
30/6/202316:15EDGAR2Form 8-K - Current report
24/5/202307:00GLOBEIkena Oncology to Participate in Upcoming Investor..
15/5/202306:50GLOBEIkena Oncology Reports First Quarter 2023 Financial Results..
15/5/202306:45GLOBEIkena Oncology Announces $40 Million Underwritten Offering

Su Consulta Reciente

Delayed Upgrade Clock